Peishun Shou

13PUBLICATIONS
32CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 05, 2026
High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemia.

|Oct 19, 2023
MHC class Ib-restricted CD8+ T cells possess strong tumoricidal activities.

Qing Li, Liangyu Lin, Peishun Shou

|Nov 08, 2021
Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid Tumors.

Koichi Hirabayashi, Hongwei Du, Yang Xu

|Apr 16, 2021
CAR T cells Targeting Human Immunoglobulin Light Chains Eradicate Mature B-cell Malignancies While Sparing a Subset of Normal B Cells.

Raghuveer Ranganathan, Peishun Shou, Sarah Ahn

|Apr 02, 2021
Fully human antibody VH domains to generate mono and bispecific CAR to target solid tumors.

Guanmeng Wang, Xin Zhou, Giovanni Fucà

|Feb 06, 2021
Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling.

Elisa Landoni, Giovanni Fucá, Jian Wang

Pageof 3

Frequent Collaborators

3 joint publications

Hongwei Du

2 joint publications

Gianpietro Dotti

2 joint publications

Feifei Song

2 joint publications

Soldano Ferrone